Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K242086
    Date Cleared
    2024-10-24

    (99 days)

    Product Code
    Regulation Number
    878.4816
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    MagDI System (MAG-01, DS-01)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The GT Metabolic MagDI System is intended for use in the creation of side duodeno-ileal anastomoses in minimally invasive and laparoscopic surgery. Once wound strength is sufficient to maintain the anastomosis, the device is passed from the body. The effects of this device on weight loss were not studied.

    The GT Metabolic MagDI System is intended for use in adult patients > 21years.

    Device Description

    The set of two (2) Magnets is a sterile single-use device. The device provides a simple method for the creation of a round (oval/circular) compression anastomosis.

    After a period of 7-21 days, a compression-induced necrosis of the tissue between the Magnets occurs and the whole device, together with the necrosed tissue that was compressed by the Magnets, detaches, and is naturally expelled with the stool.

    AI/ML Overview

    The provided text is a 510(k) Summary for the GT Metabolic MagDI System. It describes the device, its intended use, and summarizes performance testing to support its substantial equivalence to a predicate device. However, this document does not contain explicit acceptance criteria or a detailed study proving the device meets specific acceptance criteria with reported performance metrics in a readily extractable format.

    Instead, the document focuses on demonstrating substantial equivalence to a predicate device based on:

    • Same intended use and indications for use.
    • Same or similar technological characteristics (with specified changes).
    • Performance testing (pre-clinical and clinical summaries).

    Here's an attempt to answer your questions based on the available information, noting where information is not present in the document:

    1. A table of acceptance criteria and the reported device performance

    The document does not explicitly state acceptance criteria in a quantitative table format. It describes the findings of tests performed, which imply successful outcomes but don't define the pre-established thresholds for those successes.

    Acceptance Criteria (Implied from Text)Reported Device Performance
    Biocompatibility ISO 10993-1Device demonstrated biocompatibility
    Magnet field strength safety (ferromagnetic implants/devices)Magnet field strength characterized, distances safe for patients/users
    Magnets maintain adequate separation forcesMagnets maintain adequate separation forces over use life
    Magnets connect and disconnect to Delivery SystemMagnets connect and disconnect to Delivery System over use life
    Patient-contacting materials conform to ISO 10993-1 / FDA GuidancePatient-contacting materials conform to ISO 10993-1 and FDA Guidance
    Sterility Assurance Level (SAL) of 10^-6MagDI System demonstrates a SAL of 10^-6, continued sterility through shelf life
    Chronic porcine animal testingConducted over 6-week period (details not provided)
    Clinical performance (anastomosis creation, passage, AEs)Magnets successfully placed, alignment achieved, device passed naturally. Most adverse events (AEs) low grade (Clavien-Dindo Classification I-II), SAEs resolved without sequelae. No internal hernia, bowel obstruction, anastomotic bleeding, leakage, infection, or deaths. Performed safely and as intended.
    Compliance with 21 CFR 801 and ISO 15223Labeling conforms to 21 CFR 801 and ISO 15223

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Sample Size: The clinical testing summary states, "The Magnets were successfully placed in all cases... and for all subjects reaching the one-month study visit, the device passed naturally as a set of connected Magnets..." This phrasing implies that "all cases" or "all subjects" were monitored, but the exact number of subjects for the clinical test set is not provided in this document.
    • Data Provenance:
      • Country of Origin: Not specified in the given text.
      • Retrospective or Prospective: "Clinical testing was conducted in obese patients with or without type 2 diabetes mellitus using the MagDI System for creation of a side-to-side duodeno-ileal anastomosis." This describes an active study (prospective).

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This information is not provided in the document. The document summarizes clinical outcomes without detailing the mechanism or personnel involved in establishing "ground truth" for those outcomes beyond standard clinical observation and reporting.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not provided in the document.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • MRMC Study: No, the device is a physical medical device (Magnetic Compression Anastomosis System), not an AI/software device that involves "human readers" interpreting data. Therefore, an MRMC comparative effectiveness study involving AI assistance for human readers is not relevant to this device's evaluation and was not performed.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • No, this is a physical medical device, not a standalone algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    For the clinical testing, the "ground truth" seems to be based on:

    • Clinical observation/outcomes data: Successful placement, alignment, natural passage of the device, incidence of adverse events (SAEs, internal hernia, bowel obstruction, anastomotic bleeding, leakage, infection, obstruction, deaths), and assessment of patent anastomoses.
    • Imaging/surgical observation (implied): To confirm placement and alignment.

    8. The sample size for the training set

    This information is not provided in the document. The document details a clinical test (performance evaluation) but does not mention a "training set" in the context of device development, which is typically relevant for machine learning algorithms.

    9. How the ground truth for the training set was established

    Not applicable, as no training set (for an algorithm) is mentioned in the document.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1